Our deep knowledge and experience of healthcare, plus our extensive network and thorough processes will enable you to see your way forward. And we don’t just recommend, we do.
Are you planning on commercializing a product in Canada? More and more companies are establishing a Canadian presence. Pangaea has developed a detailed Critical Path that includes every step in the process, plus timing and costs to successfully launch your product in Canada.
We thought we had a view of the introduction of biosimilars in Canada which was similar to Europe. It turns out that brand is an active player and private and public payers are trying to treat them as interchangeable. Pangaea can help you stay on top of recent developments and the implications.
Given the dramatic changes in the payer environment, both public and private, the variance from currently used forecast models is significant. Pangaea can help improve launch forecasting accuracy.
The Pangaea team represents a wide range of industry experience and capabilities, which they are able to apply in a very practical and cost effective manner. Going forward, I anticipate that we will continue to work with the Pangaea team on pre launch planning and market development projects.
—James Hall, Vice President Sales & Marketing , Astellas Canada
© 2017 Pangaea Holdings Inc. / Pangaea Group